Examining Telehealth for Abortion Care and Health Equity

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates how telehealth services for reproductive healthcare impact the timing, costs, and follow-up care for patients seeking abortion. It aims to understand whether telehealth reaches individuals in areas with significant health inequities and to identify the features of telehealth that patients prefer. The study will involve 2,000 participants, divided into two groups: those seeking medication abortion care in-person and those using telehealth. The findings will help optimize telehealth services for marginalized communities, including people of color, low-income individuals, and immigrants.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Must be currently or about to be obtaining medication abortion care through in-person or telehealth services

Exclusion Criteria:

* Not currently or about to be obtaining medication abortion care through in-person or telehealth services

Where it's running

• Advancing New Standards in Reproductive Health (ANSIRH)
  Oakland, California, United States Recruiting

Study contacts

• Principal investigator: Ushma Upadhyay, PhD, MPH — University of California, San Francisco
• Study coordinator: Ushma Upadhyay, PhD, MPH
• Email: ushma.upadhyay@ucsf.edu
• Phone: 415-353-4626

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Diphenhydramine added to standard sedation for first-trimester abortion

  This trial tests whether giving diphenhydramine with standard moderate sedation improves pain control during first-trimester uterine aspiration for adults.

  Recruiting Phase 4 University of Rochester · Rochester, New York · NCT07542730

• Cabergoline to prevent lactation and ease breast symptoms after abortion or pregnancy loss

  This trial will test whether a single 1 mg oral dose of cabergoline can prevent lactation and reduce breast symptoms in people aged 18 and older having an abortion or pregnancy loss at 12–18 weeks.

  Recruiting Phase 2 Maimonides Medical Center · Brooklyn, New York · NCT07492160

• Paracervical Block With Ketorolac and Lidocaine for Osmotic Dilator Placement

  This study tests whether a ketorolac and lidocaine injection around the cervix improves pain control for people needing osmotic dilators before a second-trimester abortion.

  Recruiting Phase 2 Rush University Medical Center · Chicago, Illinois · NCT07487246

• Quick point-of-care hormone testing to manage very early medical abortion

  This will see if a quick point-of-care blood test can detect pregnancy hormone changes sooner than the usual Day 7 for people having a medical abortion before six weeks.

  Recruiting University of Edinburgh · Gothenburg and 2 other locations · NCT07417787

• Tranexamic acid to reduce bleeding during second-trimester dilation and evacuation

  We will test whether giving prophylactic tranexamic acid before a second-trimester dilation and evacuation reduces bleeding for people aged 18 and older at 18–24 weeks of pregnancy.

  Recruiting at 3 sites Phase 4 University of California, San Diego · San Diego, California and 2 other locations · NCT06820177

• Using Letrozole or Mifepristone for Medical Termination of Pregnancy

  This study is testing if letrozole can be a more effective and affordable option than mifepristone for women having a medical abortion in the first trimester.

  Recruiting Phase 4 KK Women's and Children's Hospital · Singapore · NCT05341817

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.